Hampton University Goes to Court to Try and Save Its Pharmacy Doctoral Program

Hampton University, the historically Black educational institution in Virginia, has filed a lawsuit against the American Council for Pharmacy Education. Earlier this year, the accrediting body withdrew the accreditation of the pharmacy doctorate program at the university. The university appealed the decision which was denied. The university is now going to court in an effort to rescue the doctoral program and asked for a temporary injunction that would continue the program’s accreditation while the litigation runs its course. This request was denied.

The lawsuit claims that the decision to revoke the accreditation of the pharmacy doctoral program resulted from a process that “can only be described as a bizarrely contradictory and Kafkaesque bureaucratic process rife with bias and revenge.” The complaint goes on to say that if this  “arbitrary action is not reversed, then the accrediting agency will have unilaterally terminated an extremely important community-oriented pharmacy program at one of the nation’s premier historically Black colleges and universities during a pandemic that has disproportionately impacted those communities which the Hampton University School of Pharmacy serves.”

One of the problems is a low passage rate for Hampton students on the North American Pharmacist Licensure Examination. In 2018, only 73 percent of Hampton graduates passed the examination on their first try. This was the seventh-lowest rate in the country among the 130 accredited pharmacy schools. The national average was an 89 percent success rate. Hampton has made progress in this regard, the NAPLEX pass rate had been below 60 percent in 2016. The accrediting agency also pointed out that the doctoral program had a very high attrition rate, reaching as high as three times the national average.

Related Articles

3 COMMENTS

  1. It appears to me that Hampton University Pharmacy program faculty and administrators should be ashamed and embarrassed for their academic failure and inability to adequately prepare their students for the NAPLEX exam. These higher education buffoons can’t blame the NAPLEX tests results on the accrediting body because Hampton Univ. pharmacy faculty and administrators control how they PREPARE their students. In my view, all of those persons at Hampton’s pharmacy program should minimally return their salaries or resign because they didn’t earn it due to the abysmal NAPLEX passage rates. I just bet they spend more time and energy preparing for their next homecoming as compared to preparing for the NAPLEX.

  2. Stop complaining and blaming Hampton’s NAPLEX sub par performance on the American Council for Pharmacy Education and just do the ACADEMIC work. No more excuses in 2020 and beyond.

Leave a Reply

Get the JBHE Weekly Bulletin

Receive our weekly email newsletter delivered to your inbox

Latest News

Street Named to Honor the First Black Football Player at the University of Memphis

Rogers walked-on to the football team at what was then Memphis State University in 1968, making him the institution's first Black football player. After graduating in 1972, he spent the next four decades as a coach and administrator with Memphis-area schools.

In Memoriam: Clyde Aveilhe, 1937-2024

Dr. Aveilhe held various student affairs and governmental affairs positions with Howard University, California State University, and the City University of New York.

Ending Affirmative Action May Not Produce a More Academically Gifted Student Body

Scholars from Cornell University have found removing race data from AI applicant-ranking algorithms results in a less diverse applicant pool without meaningfully increasing the group's academic merit.

Saint Augustine’s University Will Appeal Accreditation Decision

The Southern Association of Colleges and Schools Commission on Colleges has recently voted to remove Saint Augustine's University's accreditation. The university will maintain its accreditation during the appeals process. To remain accredited, the HBCU has until February 2025 to provide evidence of its financial stability.

Featured Jobs